Agent Skills: android-navigation-3
Install and migrate to Jetpack Navigation 3. Use when implementing Navigation 3 patterns including NavDisplay, NavKey routes, deep links, multiple backstacks, scenes (dialogs, bottom sheets), or migrating from Navigation 2.
ID: hoangnguyen0403/agent-skills-standard/android-navigation-3
567164
Install this agent skill to your local
Skill Files
The files that make up android-navigation-3.
More agent skills
- cloudflare-browserControl headless Chrome via Cloudflare Browser Rendering CDP WebSocket. Use for screenshots, page navigation, scraping, and video capture when browser automation is needed in a Cloudflare Workers environment. Requires CDP_SECRET env var and cdpUrl configured in browser.profiles.
- hetzner-vps-provisioningUse this skill when the user wants to provision a Hetzner VPS, create a cloud server, deploy to Hetzner, set up a development server, configure server security (UFW, fail2ban), or estimate cloud hosting costs. Handles secure VPS provisioning with Claude Code pre-installed.
- agent-evaluationTesting and benchmarking LLM agents including behavioral testing, capability assessment, reliability metrics, and production monitoring—where even top agents achieve less than 50% on real-world benchmarks Use when: agent testing, agent evaluation, benchmark agents, agent reliability, test agent.
- npmHandle npm package installation in non-interactive environments by piping confirmations. Use when installing Node.js packages that require user confirmation prompts.
- route-to-openapiGenerates RESTful API documentation (OpenAPI 3.0 / Swagger spec) by scanning route definitions in code for Flask, FastAPI, Express, Gin, and other frameworks. Trigger when users ask about API documentation, OpenAPI, Swagger, endpoint docs, generating docs from code, or extracting endpoints.
- depmapQuery the Cancer Dependency Map (DepMap) for cancer cell line gene dependency scores (CRISPR Chronos), drug sensitivity data, and gene effect profiles. Use for identifying cancer-specific vulnerabilities, synthetic lethal interactions, and validating oncology drug targets.